FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1331950005: Product containing precisely buclizine hydrochloride 6.25 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5347901012 Acetaminophen 500 mg and buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5347902017 Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5347903010 Product containing precisely buclizine hydrochloride 6.25 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Plays role Antiemetic therapeutic role (role) false Inferred relationship Some
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Plays role Antitussive therapeutic role (role) false Inferred relationship Some
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Buclizine hydrochloride true Inferred relationship Some 1
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Buclizine hydrochloride true Inferred relationship Some 1
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Codeine phosphate true Inferred relationship Some 2
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Codeine phosphate true Inferred relationship Some 2
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Paracetamol true Inferred relationship Some 3
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Paracetamol true Inferred relationship Some 3
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 3
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 3
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Is a Product containing only buclizine and codeine and paracetamol in oral dose form (medicinal product form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start